The Translational Neurodegeneration is reputed journal publishes research related to Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Translational Neurodegeneration |
|---|---|
| Publisher | BioMed Central Ltd |
| Publication Country | United Kingdom |
| ISSN | 20479158 |
| Publication Area | Medicine; Neuroscience |
| Publication Language | ENG |
| Review Process | Anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Translational Neurodegeneration in 2026 is 19.1.
The Translational Neurodegeneration is ranked in Q1.
The Translational Neurodegeneration is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Translational Neurodegeneration. The publication fee is 2690 EUR; 3090 USD; 2290 GBP.
The journal also offers a fee waiver policy.
The Translational Neurodegeneration takes an average of 10 weeks to publish research papers.
The official website of the journal is https://translationalneurodegeneration.biomedcentral.com.
Please visit only official website of the journal to submit research papers.